Literature DB >> 14599340

Redox properties of myeloperoxidase.

Jürgen Arnhold1, Paul G Furtmüller, Christian Obinger.   

Abstract

The heme-containing enzyme myeloperoxidase (MPO) is secreted from polymorphonuclear leukocytes and monocytes. It is involved in host defence and inflammation by oxidation of numerous small molecules. This review summarises our current results on the determination of redox properties of all intermediates involved in the halogenation and peroxidase cycle of MPO. The standard reduction potentials of the redox couples compound I/native MPO, compound I/compound II of MPO, and compound II/native MPO have been determined to be 1.16 V, 1.35 V, and 0.97 V, respectively, at pH 7 and 25 degrees C. Thus, for the first time, a full description of these important thermodynamic parameters of myeloperoxidase has been performed, allowing a better understanding of its extraordinary reactivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599340     DOI: 10.1179/135100003225002664

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  17 in total

1.  Chronic intracerebroventricular delivery of the secretory phospholipase A2 inhibitor, 12-epi-scalaradial, does not improve outcome after focal cerebral ischemia-reperfusion in rats.

Authors:  Germán Torregrosa; Fernando J Pérez-Asensio; María C Burguete; María Castelló-Ruiz; Juan B Salom; Enrique Alborch
Journal:  Exp Brain Res       Date:  2007-01       Impact factor: 1.972

2.  Inhibition of Myeloperoxidase.

Authors:  Jala Soubhye; Paul G Furtmüller; Francois Dufrasne; Christian Obinger
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Myeloperoxidase expression in human colonic mucosa is related to systemic oxidative balance in healthy subjects.

Authors:  Stefano Mancini; Francesco Mariani; Paola Sena; Marta Benincasa; Luca Roncucci
Journal:  Redox Rep       Date:  2017-01-09       Impact factor: 4.412

4.  Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.

Authors:  Dhiman Maitra; Faten Shaeib; Ibrahim Abdulhamid; Rasha M Abdulridha; Ghassan M Saed; Michael P Diamond; Subramaniam Pennathur; Husam M Abu-Soud
Journal:  Free Radic Biol Med       Date:  2013-04-25       Impact factor: 7.376

5.  The fluorescein-derived dye aminophenyl fluorescein is a suitable tool to detect hypobromous acid (HOBr)-producing activity in eosinophils.

Authors:  Jörg Flemmig; Josefin Zschaler; Johannes Remmler; Jürgen Arnhold
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

6.  Imaging of innate immunity activation in vivo with a redox-tuned PET reporter.

Authors:  Federica Pisaneschi; Seth T Gammon; Vincenzo Paolillo; Sarah A Qureshy; David Piwnica-Worms
Journal:  Nat Biotechnol       Date:  2022-02-21       Impact factor: 68.164

7.  Inhibition of myeloperoxidase-mediated protein nitration by tempol: Kinetics, mechanism, and implications.

Authors:  Sandra M Vaz; Ohara Augusto
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-22       Impact factor: 11.205

8.  Multidomain human peroxidasin 1 is a highly glycosylated and stable homotrimeric high spin ferric peroxidase.

Authors:  Monika Soudi; Martina Paumann-Page; Cedric Delporte; Katharina F Pirker; Marzia Bellei; Eva Edenhofer; Gerhard Stadlmayr; Gianantonio Battistuzzi; Karim Zouaoui Boudjeltia; Paul G Furtmüller; Pierre Van Antwerpen; Christian Obinger
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

9.  N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor.

Authors:  Hao Zhang; Xigang Jing; Yang Shi; Hao Xu; Jianhai Du; Tongju Guan; Dorothee Weihrauch; Deron W Jones; Weiling Wang; David Gourlay; Keith T Oldham; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  J Lipid Res       Date:  2013-07-24       Impact factor: 5.922

10.  Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs.

Authors:  Bong-Seop Lee; Chi Woo Yoon; Arsen Osipov; Nuriel Moghavem; Daniel Nwachokor; Rina Amatya; Rebekah Na; Joe L Pantoja; Michael D Pham; Keith L Black; John S Yu
Journal:  J Drug Deliv       Date:  2011-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.